Loading insider details...
Latest Form 4 (Sep 2, 2026): Tax Withholding of 14 JAZZ shares, $3.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 14 | $3.4K |
| Aug 7, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 1,605 | n/a |
| Jul 13, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 19,000 | $160.6K |
| Jun 24, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 3,990 | n/a |
| Jun 17, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 65,921 | $557.0K |
| Jun 5, 2026 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,408 | n/a |
| Aug 11, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,507 | n/a |
| Jun 24, 2025 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 6,589 | n/a |
| Jun 5, 2025 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,037 | n/a |
| Aug 6, 2024 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,731 | n/a |